Lepu Medical Technology (Beijing) 将来の成長

Future 基準チェック /46

Lepu Medical Technology (Beijing)利益と収益がそれぞれ年間42.4%と19.4%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に9.6% 41.9%なると予測されています。

主要情報

42.4%

収益成長率

41.9%

EPS成長率

Medical Equipment 収益成長	26.6%
収益成長率	19.4%
将来の株主資本利益率	9.6%
アナリストカバレッジ	Good
最終更新日	29 Oct 2024

今後の成長に関する最新情報

Lepu Medical Technology (Beijing) Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 28

Earnings Miss: Lepu Medical Technology (Beijing) Co., Ltd. Missed EPS By 56% And Analysts Are Revising Their Forecasts

Aug 27

Recent updates

Here's Why Lepu Medical Technology (Beijing) (SZSE:300003) Can Manage Its Debt Responsibly

Nov 15

Lepu Medical Technology (Beijing) Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 28

Investors Still Aren't Entirely Convinced By Lepu Medical Technology (Beijing) Co., Ltd.'s (SZSE:300003) Earnings Despite 33% Price Jump

Oct 18

Investors Give Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Shares A 26% Hiding

Sep 02

News Flash: 7 Analysts Think Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Earnings Are Under Threat

Aug 31

Earnings Miss: Lepu Medical Technology (Beijing) Co., Ltd. Missed EPS By 56% And Analysts Are Revising Their Forecasts

Aug 27

Lepu Medical Technology (Beijing) (SZSE:300003) Might Be Having Difficulty Using Its Capital Effectively

Aug 16

Lepu Medical Technology (Beijing)'s (SZSE:300003) Dividend Is Being Reduced To CN¥0.3314

Jun 23

Lepu Medical Technology (Beijing) (SZSE:300003) Seems To Use Debt Quite Sensibly

May 31

Capital Allocation Trends At Lepu Medical Technology (Beijing) (SZSE:300003) Aren't Ideal

May 13

Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet

Feb 28

業績と収益の成長予測

SZSE:300003 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	9,729	1,951	N/A	2,548	7
12/31/2025	8,405	1,632	N/A	2,078	8
12/31/2024	6,422	980	N/A	2,112	4
9/30/2024	6,506	707	159	810	N/A
6/30/2024	7,062	994	303	1,008	N/A
3/31/2024	7,465	1,143	488	1,266	N/A
12/31/2023	7,980	1,258	146	990	N/A
9/30/2023	9,107	1,747	642	1,573	N/A
6/30/2023	9,577	1,897	794	1,754	N/A
3/31/2023	10,498	2,254	1,320	2,208	N/A
12/31/2022	10,609	2,204	1,885	2,791	N/A
9/30/2022	9,787	1,608	1,611	2,558	N/A
6/30/2022	9,473	1,262	1,118	2,106	N/A
3/31/2022	10,460	1,539	1,211	2,212	N/A
1/1/2022	10,660	1,719	2,078	3,062	N/A
9/30/2021	10,286	1,750	1,954	2,812	N/A
6/30/2021	10,321	2,387	2,269	3,086	N/A
3/31/2021	9,121	2,144	2,567	3,284	N/A
12/31/2020	8,039	1,802	1,490	2,090	N/A
9/30/2020	8,303	2,086	1,700	2,312	N/A
6/30/2020	8,112	1,710	1,899	2,424	N/A
3/31/2020	7,584	1,526	1,294	1,839	N/A
12/31/2019	7,796	1,725	1,427	1,990	N/A
9/30/2019	7,652	1,687	1,152	1,834	N/A
6/30/2019	7,323	1,564	998	1,669	N/A
3/31/2019	6,799	1,498	877	1,557	N/A
12/31/2018	6,356	1,219	429	1,501	N/A
9/30/2018	5,832	1,304	361	1,241	N/A
6/30/2018	5,310	1,214	N/A	1,063	N/A
3/31/2018	4,942	970	N/A	954	N/A
12/31/2017	4,538	899	N/A	913	N/A
9/30/2017	4,234	874	N/A	772	N/A
6/30/2017	3,974	797	N/A	728	N/A
3/31/2017	3,701	734	N/A	770	N/A
12/31/2016	3,468	679	N/A	692	N/A
9/30/2016	3,318	649	N/A	778	N/A
6/30/2016	3,113	610	N/A	693	N/A
3/31/2016	2,938	569	N/A	509	N/A
12/31/2015	2,769	521	N/A	436	N/A
9/30/2015	2,419	520	N/A	374	N/A
6/30/2015	2,208	500	N/A	363	N/A
3/31/2015	1,934	458	N/A	324	N/A
12/31/2014	1,669	423	N/A	348	N/A
9/30/2014	1,578	405	N/A	277	N/A
6/30/2014	1,490	385	N/A	284	N/A
3/31/2014	1,375	362	N/A	330	N/A
12/31/2013	1,303	362	N/A	330	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 300003の予測収益成長率 (年間42.4% ) は貯蓄率 ( 2.8% ) を上回っています。

収益対市場: 300003の収益 ( 42.4% ) はCN市場 ( 25.9% ) よりも速いペースで成長すると予測されています。

高成長収益: 300003の収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: 300003の収益 ( 19.4% ) CN市場 ( 13.8% ) よりも速いペースで成長すると予測されています。

高い収益成長: 300003の収益 ( 19.4% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 300003の自己資本利益率は、3年後には低くなると予測されています ( 9.6 %)。

Lepu Medical Technology (Beijing) 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Consensus EPS estimates fall by 28%

Lepu Medical Technology (Beijing) Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Consensus revenue estimates fall by 20%

Earnings Miss: Lepu Medical Technology (Beijing) Co., Ltd. Missed EPS By 56% And Analysts Are Revising Their Forecasts

Consensus revenue estimates fall by 17%

Price target decreased by 11% to CN¥20.69

Recent updates

Here's Why Lepu Medical Technology (Beijing) (SZSE:300003) Can Manage Its Debt Responsibly

Consensus EPS estimates fall by 28%

Lepu Medical Technology (Beijing) Co., Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Investors Still Aren't Entirely Convinced By Lepu Medical Technology (Beijing) Co., Ltd.'s (SZSE:300003) Earnings Despite 33% Price Jump

Investor sentiment deteriorates as stock falls 23%

Lepu Medical Technology (Beijing) Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024

New minor risk - Share price stability

Investor sentiment improves as stock rises 24%

Lepu Medical Technology (Beijing) Co., Ltd. Approves Interim Cash Dividend on A Shares for the 2024, Payable on 20 September 2024

Lepu Medical Technology (Beijing) Co., Ltd. Approves 2024 Interim Profit Cash Dividend (Tax Included)

Investors Give Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Shares A 26% Hiding

Consensus revenue estimates fall by 20%

News Flash: 7 Analysts Think Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) Earnings Are Under Threat

Earnings Miss: Lepu Medical Technology (Beijing) Co., Ltd. Missed EPS By 56% And Analysts Are Revising Their Forecasts

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Lepu Medical Technology (Beijing) (SZSE:300003) Might Be Having Difficulty Using Its Capital Effectively

Lepu Medical Technology (Beijing) Co., Ltd. to Report First Half, 2024 Results on Aug 24, 2024

Lepu Medical Technology (Beijing)'s (SZSE:300003) Dividend Is Being Reduced To CN¥0.3314

Dividend reduced to CN¥0.33

Lepu Medical Technology (Beijing) Co., Ltd. Implements 2023 Final Profit Distribution for A Shares, Payable on 27 June 2024

Lepu Medical Technology (Beijing) (SZSE:300003) Seems To Use Debt Quite Sensibly

Capital Allocation Trends At Lepu Medical Technology (Beijing) (SZSE:300003) Aren't Ideal

Consensus revenue estimates fall by 17%

Price target decreased by 11% to CN¥20.69

Lepu Medical Technology (Beijing) Co., Ltd., Annual General Meeting, May 15, 2024

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Lepu Medical Technology (Beijing) Co., Ltd. to Report Q1, 2024 Results on Apr 20, 2024

Lepu Medical Technology (Beijing) (SZSE:300003) Has A Pretty Healthy Balance Sheet

Investor sentiment improves as stock rises 15%

Lepu Medical Technology (Beijing) Co., Ltd. to Report Fiscal Year 2023 Results on Apr 20, 2024

Price target decreased by 10% to CN¥24.02

Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) announces an Equity Buyback for CNY 500 million worth of its shares.

Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003) announces an Equity Buyback for CNY 500 million worth of its shares.

New minor risk - Share price stability

Investor sentiment improves as stock rises 16%

Lepu Medical Technology (Beijing) Co., Ltd. to Report Q3, 2023 Results on Oct 26, 2023

Price target decreased by 8.6% to CN¥28.09

Consensus revenue estimates fall by 11%

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Lepu Medical Technology (Beijing) Co., Ltd. Announces Final Profit Distribution for 2022, Payable on 30 June 2023

Lepu Medical Technology (Beijing) Co., Ltd. Approves the Election of Wang Qihong as Non-Independent Director and Qu Xin as Independent Director

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Insufficient new directors

Price target increased to CN¥31.40

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Lepu Medical Technology (Beijing) Co., Ltd. has completed a Follow-on Equity Offering in the amount of $224.238141 million.

Consensus forecasts updated

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Lepu Medical Technology (Beijing) Co., Ltd. Announces Final Profit Distribution on Share A for 2021, Payable on June 30, 2022

Lepu Medical Technology (Beijing) Co., Ltd. Approves Cash Dividend for the Year 2021

Price target decreased to CN¥29.12

Lepu Medical Technology (Beijing) Co., Ltd. Proposes Dividend for 2021

First quarter 2022 earnings: EPS misses analyst expectations

Now 22% undervalued after recent price drop

Now 22% undervalued after recent price drop

Investor sentiment deteriorated over the past week

Price target decreased to CN¥35.05

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS CN¥0.56 (vs CN¥0.43 in 2Q 2020)

Lepu Medical Technology (Beijing) Co., Ltd. Approves Cash Dividend for the Year 2020

First quarter 2021 earnings released: EPS CN¥0.41 (vs CN¥0.22 in 1Q 2020)

Consensus EPS estimates fall to CN¥1.24

Lepu Medical Technology (Beijing) Co., Ltd. Proposes Cash Dividend for the Year 2020

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥1.07 (vs CN¥0.97 in FY 2019)

Lepu Medical Technology (Beijing) Co., Ltd. to Report Fiscal Year 2020 Results on Mar 31, 2021

Investor sentiment improved over the past week